Abstract
Cardiovascular complications are the principal cause of death in dialysis patients. Records of the European Dialysis and Transplant Association [1] show that 52.1% of such patients die from cardiovascular complications, with left ventricular insufficiency and coronary insufficiency being the most frequent causes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Geerling W, Tufveson G, Broyer M, Brunner FP, Brynger H, Fassbinder W. 1983. Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 17:52–54.
Burke JF, Francos GC, Moore LL, Cho YS, Lasker N. 1978. Accelerated atherosclerosis in chronic dialysis patients. Nephron 21:181–187.
Drüeke T, Le Pailleur C, Meilhac B, Koutoudis C, Zingraff J, Di Matteo J, Crosnier J. 1977. Congestive cardiomyopathy in uraemic patients on long term haemodialysis. Br Med J 1:350–353.
Raab W. 1944. Cardiotoxic substances in the blood and the heart muscle in uremia. J Lab Clin Med 29:715–734.
Lindner A, Charra B, Sherrer DJ, Scribner BH. 1974. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697–701.
O’Rourke MF. 1982. Arterial Function in Health and Disease. Edinburgh: Churchill Livingstone.
Cohen MV, Diaz P, Scheuer J. 1979. Echocardiographic assessment of left ventricular function in patients with chronic uremia. Clin Nephrol 12:156–162.
Lai KN, Ng J, Whitford J, Buttfield, Fassett RG, Mathew TH. 1985. Left ventricular function in uremia: echocardiographic and radionuclide assessment in patients on maintenance hemodialysis. Clin Nephrol 23:125–133.
London GM, Fabiani F, Marchais SJ, de Vernejoul M-C, Guérin AP, Safar ME, Métivier F, Llach F. 1987. Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. Kidney Int 31:973–980.
Hütting J, Kramer W, Schütterle G, Wizemann V. 1988. Analysis of left-ventricular changes associated with chronic hemodialysis. A non-invasive follow-up study. Nephron 49: 284–290.
Sahn DJ, De Maria A, Kisslo J, Weyman A. 1978. Recommendations regarding quantitation in M-mode echocardiographic measurements. Circulation 58:1073–1083.
Devereux RB, Reichek N. 1977. Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 55:613–618.
Teicholz LE, Kreulen T, Herman MV, Gorlin R. 1976. Problems in echocardiographic volume determinations. Echocardiographic-angiographie correlations in the presence or absence of asynergy. Am J Cardiol 37:7–11.
Spirito P, Maron BJ, Bonow RO. 1986. Noninvasive assessment of left ventricular diastolic function: Comparative analysis of Doppler echocardiographic and radionuclide angiographie techniques. J Am Coll Cardiol 7:518–526.
Friedman BJ, Drinkovic N, Miles H, Shih WJ, Mazzoleni A, DeMaria AN. 1986. Assessment of left ventricular diastolic function: Comparison of Doppler echocardiography and gated blood pool scintigraphy. J Am Coll Cardiol 8:1348–1354.
Avolio AP, Deng FQ, Li DQ, Luo YF, Huang ZD, Xing LF, O’Rourke MF. 1985. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 71: 202–210
London GM, Marchais, SJ, Safar ME, Genest AF, Guérin AP, Métivier F, Chedid K, London AM. 1990. Aortic and large artery compliance in end-stage renal failure. Kidney Int 37:137–142.
Savage DD, Levy D, Dannenberg AL, Garrison RJ, Castelli WP. 1990. Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (The Framingham Study) Am J Cardiol 65:371–376.
Chaignon M, Chen WT, Tarazi RC, Bravo EL, Nakamoto S. 1981. Effect of hemodialysis on blood volume distribution and cardiac output. Hypertension 3:327–332.
Macdonald IL, Uldall R, Buda AJ. 1981. The effect of hemodialysis on cardiac rhythm and performance. Clin Nephrol 6:321–327.
Nixon JV, Mitchell JH, McPhaul JJ, Henrich WL. 1983. Effect of hemodialysis on left ventricular function. J Clin Invest 71:377–384.
Hiiting J, Kramer W, Charra B, Laurent G, Wizemann V. Schütterle G. 1989. Asymétrie septal hypertrophy and left atrial dilatation in patients with end-stage renal disease on long-term hemodialysis. Clin Nephrol 32:276–283.
Bullock RE, Amer HA, Simpson I, Ward MK, Hall RJC. 1984. Cardiac abnormalities and exercise tolerance in patients receiving renal replacement therapy. Br Med J 289:1479–1484.
Friedman HS, Shah BN, Kim HG, Bove LA, Del Monte MM, Smith AJ. 1981. Clinical study of the cardiac findings in patients on chronic maintenance hemodialysis: the relationship to coronary risk factors. Clin Nephrol 16:75–85.
Löw I, rützmacher P, Bergmann M, Schoeppe W. 1989. Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin. Clin Nephrol 31:26–30.
London GM, Marchais SJ, Guérin AP, Fabiani F, Métivier F. 1990. Fonction cardio-vasculaire du sujet hémodialysé. In Hamburger J, Funck-Brentano JL, Bach JF, Kreis H, Grünfeld JP(eds), Actualités Néphrologiques. Paris: Flammarion Médecine-Science, pp. 283–301.
Ahearn DJ, Mäher JF. 1972. Heart failure as a complication of hemodialysis fistula. Ann Intern Med 77:201–204.
Anderson CB, Codd JR, Graff RA, Groce MA, Harter HR, Newton WT. 1976. Cardiac failure and upper extremity arteriovenous dialysis fistula. Arch Intern Med 3:292–297.
Ponsin JC, Levy B, Martineaud JP. 1983. Retentissement cardiaque du débit de la fistule artério-veineuse: étude chez 66 hémodialysés chroniques. Presse Med 12:217–221.
Chaignon M, Chen WT, Tarazi RC, Nakamoto S, Salcedo E. 1982. Acute effects of hemodialysis on echographic-determined cardiac performance: improved contractility resulting with serum increased calcium with reduced potassium despite hypovolemic-induced cardiac output. Am Heart J 103:374–380.
Gerry JL, Baird MG, Fortuin NJ. 1976. Evaluation of left ventricular function in patients with sickle cell anemia. Am J Med 60:968–972.
Silberberg JS, Rahal DP, Patton R, Sniderman AD. 1989. Role of anemia in the pathogenesis of left ventricular hypertrophy in endstage renal disease. Am J Cardiol 64: 222–224.
London GM, Zins B, Pannier B, Naret C, Berthelot J-M, Jacquot C, Safar M, Drüeke TB. 1989. Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int 36:878–882.
Macdougall IC, Lewis NP, Saunders MJ, Cochlin DL, Davies ME, Hutton RD, Fox FAA, Coles GA, Williams JD. 1990. Long-term cardiorespiratory effects of amelioration of renal anemia by erythropoietin. Lancet 335:489–493.
Gaasch WH.1979. Left ventricular radius to wall thickness ratio. Am J Cardiol 43: 1189–1194.
Grossman W, Jones D, McLaurin LP. 1975. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56:56–64.
Katz R, Karliner JS, Resnick R. 1978. Effects of natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation 58:434–440.
Ikram H, Lynn KL, Bailey RR, Little PJ. 1983. Cardiovascular changes in chronic hemodialysis patients. Kidney Int 24:371–376.
Miach PJ, Dawborn JK, Louis WJ, McDonald IG. 1981. Left ventricular function in uremia: echocardiographic assessment in patients on maintenance dialysis. Clin Nephrol 5:259–263.
Ritz E, Rambausek M, Mall G, Ruffmann K, Schmidli M, Huther W. 1987. Cardiac hypertrophy in uremia. In Châtelain C, Jacobs C(eds), Séminaires d’uro-néphrologie. Paris: Masson, pp. 195-205.
Harnett JD, Parfrey PS, Griffiths SM, Gault MH, Barre P, Guttmann RD. 1988. Left ventricular hypertrophy inend-stag renal disease. Nephron 48:107–115.
Silberberg JS, Barre PE, Prichard SS, Sniderman AD. 1989. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286–290.
Maron BJ. 1985. Asymmetry in hypertrophic cardiomyopathy: The septal to free wall thickness ratio revised. Am J Cardiol 55:835–838.
Bernardi D, Bernini L, Cini G, Ghione S, Bonechi I. 1985. Asymmetric septal hypertrophy and sympathetic overactivity in normotensive hemodialyzed patients. Am Heart J 109: 539–545.
Heng MK, Janz RF, Jobin J. 1985. Estimation of regional stress in the left ventricular septum and free wall: an echocardiographic study suggesting a mechanism for septal hypertrophy. Am Heart J 110:84–90.
Mall G, Rambausek M, Neumeister A, Kollmar S, Vetterlein F, Ritz E. 1988. Myocardial interstitial fibrosis in experimental uremia-implications for cardiac compliance. Kidney Int 33:804–811.
Rambausek M, Ritz E, Mall G, Mehls O, Katus H. 1985. Myocardial hypertrophy in rats with renal insufficiency. Kidney Int 28:775–782.
London GM, de Vernejoul M-C, Fabiani F, Marchais SJ, Guérin AP, Métivier F, London AM, Llach F. 1987. Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. Kidney Int 32:900–907.
Himelman RB, Landzberg JS, Simonson JS, Amend W, Bouchard A, Merz R, Schiller NB. 1988. Cardiac consequences of renal transplantation: changes in left ventricular morphology and function. J Am Coll Cardiol 12:915–923.
Moalic JM, Swynghedauw B. 1987. Regulation of gene expression in the normal and overloaded heart. InLegato MJ(ed), The Stressed Heart. Boston: Martinus-Nijhoff, pp. 1–18.
Lehr D. 1966. The role of certain electrolytes and hormones in disseminated myocardial necrosis. In Bajusz E(ed), Electrolyte and Cardiovascular Disease. Basel: Karger, pp. 248–249.
Penpargkul S, Scheuer J. 1972. Effect of uraemia upon the performance of the rat heart. Cardiovasc Res 6:702–708.
Scheuer J, Stezoski SW. 1973. The effect of uremic compounds on cardiac function and metabolism. J Mol Cell Cardiol 4:287–300.
Baczinski R, Massry SG, Kohan R, Magott M, Saglikes Y, Brautbar N. 1985. Effect of parathyroid hormone on myocardial energy metabolism in rat. Kidney Int 27:718–725.
Bogin E, Massry SG, Harary I. 1981. Effect of parathyroid hormone on heart cells. J Clin Invest 67:1215–1227.
Kraikipanitch S, Lindeman RD, Yoenice AA, Baxter DJ, Jaygrod CC, Blue MM. 1978. Effect of azotemia on myocardial accumulation of calcium. Mineral Electrol Metab 1:12–20.
Arora KK, Lacy JP, Schacht RA, Martin DG, Gutch CF. 1975. Calcific cardiomyopathy in advanced renal failure. Arch Intern Med 4:603–605.
Rostand SG, Sanders C, Kirk, KA, Rutsky EA, Fraser RG. 1988. Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 85:651–657.
Terman DS, Alfrey AC, Hammond WS, Donndelinger T, Ogden DA, Holmes JH. 1971. Cardiac calcification in uremia: A clinical, biochemical and pathologic study. Am J Med 50:744–755.
D’Cruz IA, Bhatt GR, Cohen HC, Glick G. 1978. Echocardiographic detection of cardiac involvement in patients with chronic renal failure. Arch Intern Med 138:720–724.
Maher ER, Pazianas M, Curtis JR. 1987. Calcific aortic stenosis: a complication of chronic uraemia. Nephron 47:119–122.
Kramer W, Wizemann V, Lammlein G, Thormann J, Kindler M, Schelpper M, Schutterle G. 1986. Cardiac dysfunction in patients on maintenance hemodialysis II: systolic and diastolic properties of the left ventricle assessed by invasive methods. In Berline GM, Giovannetti S(ed), Heart in End-Stage Renal Failure. Contrib Nephrol 52:97–109.
Lewis BS, Milne FJ, Goldberg B. 1976. Left ventricular function in chronic renal failure. Br Heart J 38:1229–1239.
Kettner A, Goldberg A, Hagberg J, Delmez J, Harter H. 1984. Cardiovascular and metabolic responses to submaximal exercise in hemodialysis patients. Kidney Int 26:66–71.
London GM, Guérin AP, Marchais SJ, Métivier F. 1989. Cardiomyopathy in end-stage renal failure. Semin Dial 2:102–107.
Grossman W, McLaurin LP. 1976. Diastolic properties of the left ventricle. Ann Intern Med 84:316–326.
Textor SC, Gavras H, Tifft CP, Bernard DB, Idelson B, Brunner HR. 1981. Norepinephrine and plasma renin activity in chronic renal failure: Evidence for interacting roles in hemodialysis hypertension. Hypertension 3:294–299.
Topol EJ, Traill TA, Fortuin NJ. 1985. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 312:277–283.
Kessler KM. 1988. Heart failure with normal systolic function: update of prevalence, differential diagnosis, prognosis, and therapy. Arch Intern Med 148:2109–2111.
Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Fröhlich ED.1984. Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. AmJ Med 77:18–22.
Wicker P, Tarazi RC. 1982. Flux coronaire dans l’hypertrophie ventriculaire gauche: revue des données expérimentales. In Brutsaert DL(ed), L’hypertrophie ventriculatire gauche. Paris: Masson, pp. 115–123.
McLenachan JM, Henderson E, Morris Kl, Dargie HJ. 1987. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 317:787–792.
Morrison G, Michelson EL, Brown S, Morganroth J. 1980. Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 17:811–819.
Deligiannis A, Paschalidou E, Sakellariou G, Vargemezis V, Geleris P, Kontopoulos A, Papadimitriou M. 1984. Changes in left ventricular anatomy during haemodialysis, continuous ambulatory peritoneal dialysis and after renal transplantation. Proc EDTA-ERA 21:185–189.
Marchais S, Guérin P, Safar S, London G. 1989. Arterial compliance in uremia. J Hypertension 7(Suppl 6):S84–S85.
Rostand SG, Grefes JC, Kirk KA, Rutsky EA, Andreoli TE. 1979. Ischémie heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16:600–611.
Nakashima T, Tanikawa J. 1971. A study of human aortic distensibility with relation to atherosclerosis and aging. Angiology 22:477–483.
Avolio A, O’Rourke M, Clyde K, Simmons L. 1985. Change of arterial distensibility with age in subjects with familiar hypercholesterolemia. Aust NZ J Med Suppl 2:56.
Ibels LS, Alfrey Al, Huffer WE, Craswell PW, Anderson JT, Weil R. 1979. Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 66:790–796.
Haynes FW, Ellis LB, Weiss S. 1936. Pulse wave velocity and arterial elasticity in arterial hypertension, arteriosclerosis and related conditions. Am Heart J 11:385–411.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
London, G.M., Fabiani, F. (1992). Left Ventricular Dysfunction in End-Stage Renal Disease: Echocardiographic Insights. In: Parfrey, P.S., Harnett, J.D. (eds) Cardiac Dysfunction in Chronic Uremia. Topics in Renal Medicine, vol 10. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3902-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3902-5_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6741-3
Online ISBN: 978-1-4615-3902-5
eBook Packages: Springer Book Archive